RecruitingNCT06882785
KarXT for schizophrenia
This study is recruiting in Japan. It is testing KarXT for schizophrenia.
Multiple locations, including KōnanSchizophreniaDrugA study involving a medication or substance.From 18 Years to 65 Years
Study directory
Back to overviewMental health studies with practical context.
Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
RecruitingNCT07065240
SPT-300 (GlyphAllo) for depression
This study is recruiting in the United States, in Bulgaria, in Czechia, .... It is testing SPT-300 (GlyphAllo) for depression.
Multiple locations, including ChinoDepressionDrugFrom 18 Years to 65 Years
RecruitingNCT06223880
Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms
This study is recruiting in the United States. It is testing Efficacy of AXS-05 Compared to Bupropion for depression.
Multiple locations, including BellflowerDepressionDrugFrom 18 Years to 65 Years
RecruitingNCT07193901
Safety study of Efficacy, Safety, and Pharmacokinetic Characteristics of (R)-Ketamine Hydrochloride Nasal Spray in depression
This study is recruiting in China. It is testing Efficacy, Safety, and Pharmacokinetic Characteristics of (R)-Ketamine Hydrochloride Nasal Spray for depression.
Multiple locations, including BeijingDepression, SuicidalityDrugFrom 18 Years to 64 Years
RecruitingNCT07424404
KarXT and KarX-EC for schizophrenia
This study is recruiting in the United States, in France, in Canada, .... It is testing KarXT and KarX-EC for schizophrenia.
Multiple locations, including AnaheimSchizophreniaDrugFrom 5 Years to 17 Years
RecruitingNCT07196501
Maintenance Effect of NBI-1065845 for depression
This study is recruiting in the United States, in Australia, in Canada, .... It is testing Maintenance Effect of NBI-1065845 for depression.
Multiple locations, including OceansideDepressionDrugOver 18 Years
RecruitingISRCTN18346744
Safety study of NTX-1955 in anxiety
This study is recruiting in the United Kingdom. It is testing NTX-1955 for anxiety.
In United KingdomAnxietyOtherFrom 18 Years to 55 Years
RecruitingNCT07061288
Safety, Tolerability, and PK of an Injectable Form of KarXT
This study is recruiting in the United States. It focuses on Schizophrenia.
Multiple locations, including Los AlamitosSchizophreniaDrugFrom 18 Years to 55 Years
RecruitingNCT07621237
TNX-102 SL Monotherapy Versus Placebo in people with Major Depressive Disorder (MDD)
This study is recruiting in the United States. It is testing TNX-102 SL Monotherapy for depression.
Multiple locations, including PhoenixDepressionDrugOver 18 Years
RecruitingISRCTN15349263
A study to explore the suitability of group online peer support, music, and health education interventions to caregivers of unsettled babies with colic, reflux, and/or cow's milk protein allergy
This study is recruiting in the United Kingdom. It focuses on Anxiety.
In United KingdomAnxiety, DepressionOtherFrom 18 Years to 100 Years
RecruitingISRCTN11841241
A study to help identify depression in patients aged 65 years and older who are registered with a GP in the North of England
This study is recruiting in the United Kingdom. It focuses on depression.
In United KingdomDepressionOtherOver 65 Years
RecruitingISRCTN13501446
A study to improve quality of life of people with long term conditions in Colombia using Dynamic DIALOG+
This study is looking at whether a digital support tool can help people with Diabetes, anxiety, depression, diabetes, obesity, hypertension,hazardous alcohol consumption or Mental and Behavioural Disorders. Participants receive a study treatment and complete follow-up visits and assessments.
In ColombiaAnxiety, DepressionOtherFrom 18 Years to 65 Years
Public registry coverage is progressing
HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.